Observational studyCurrent oncology (Toronto, Ont.)2026
Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study.
Thomas Pierret et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.